Used as a key chiral intermediate in the synthesis of antidiabetic drugs, particularly DPP-4 inhibitors like sitagliptin. Its stereochemistry enables high selectivity and potency in pharmaceutical formulations. Commonly employed in asymmetric synthesis to introduce fluorinated aromatic moieties into bioactive molecules. Also utilized in research for developing enzyme inhibitors and peptide-based therapeutics.